Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.
Derlin T, Schultze-Florey C, Werner RA, Möhn N, Skripuletz T, David S, Beutel G, Eder M, Ross TL, Bengel FM, Ganser A, Koenecke C. Derlin T, et al. Among authors: beutel g. Ann Nucl Med. 2021 Jan;35(1):132-138. doi: 10.1007/s12149-020-01544-w. Epub 2020 Nov 11. Ann Nucl Med. 2021. PMID: 33174144 Free PMC article.
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy.
Möhn N, Bonda V, Grote-Levi L, Panagiota V, Fröhlich T, Schultze-Florey C, Wattjes MP, Beutel G, Eder M, David S, Körner S, Höglinger G, Stangel M, Ganser A, Koenecke C, Skripuletz T. Möhn N, et al. Among authors: beutel g. Neurol Res Pract. 2022 Jan 10;4(1):1. doi: 10.1186/s42466-021-00166-5. Neurol Res Pract. 2022. PMID: 35000613 Free PMC article.
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.
Stadler M, Venturini L, Bünting I, Dammann E, Weissinger EM, Schwarzer A, Schultze-Florey C, Ehrlich S, Markel D, Lueck C, Gladysz A, Fröhlich T, Damrah N, Beutel G, Eder M, Ganser A, Hambach L. Stadler M, et al. Among authors: beutel g. Front Oncol. 2022 Aug 17;12:867356. doi: 10.3389/fonc.2022.867356. eCollection 2022. Front Oncol. 2022. PMID: 36059667 Free PMC article.
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
Stadler M, Hambach L, Dammann E, Diedrich H, Kamal H, Hamwi I, Schultze-Florey C, Varvenne M, Ehrlich S, Buchholz S, Koenecke C, Beutel G, Weissinger EM, Krauter J, Eder M, Hertenstein B, Ganser A. Stadler M, et al. Among authors: beutel g. Ann Hematol. 2023 Sep;102(9):2529-2542. doi: 10.1007/s00277-023-05276-5. Epub 2023 Jul 25. Ann Hematol. 2023. PMID: 37490114 Free PMC article.
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.
Teich K, Stadler M, Gabdoulline R, Kandarp J, Wienecke C, Heida B, Klement P, Büttner K, Venturini L, Wichmann M, Puppe W, Schultze-Florey C, Koenecke C, Beutel G, Eder M, Ganser A, Heuser M, Thol F. Teich K, et al. Among authors: beutel g. Cancers (Basel). 2023 Aug 1;15(15):3911. doi: 10.3390/cancers15153911. Cancers (Basel). 2023. PMID: 37568726 Free PMC article.
108 results